Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 1
2000 1
2009 3
2011 3
2012 4
2013 5
2014 2
2015 2
2016 4
2017 5
2018 5
2019 13
2020 14
2021 16
2022 13
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Calciphylaxis: Treatment and outlook-CME part II.
Rick J, Rrapi R, Chand S, Shinohara MM, Strowd L, Pasieka HB, Micheletti R, Kroshinsky D, Ortega-Loayza AG. Rick J, et al. Among authors: shinohara mm. J Am Acad Dermatol. 2022 May;86(5):985-992. doi: 10.1016/j.jaad.2021.10.063. Epub 2022 Feb 22. J Am Acad Dermatol. 2022. PMID: 35202773 Review.
Calciphylaxis: Part I. Diagnosis and pathology.
Rick J, Strowd L, Pasieka HB, Saardi K, Micheletti R, Zhao M, Kroshinsky D, Shinohara MM, Ortega-Loayza AG. Rick J, et al. Among authors: shinohara mm. J Am Acad Dermatol. 2022 May;86(5):973-982. doi: 10.1016/j.jaad.2021.10.064. Epub 2022 Feb 1. J Am Acad Dermatol. 2022. PMID: 35114300 Review.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H. Horwitz SM, et al. Among authors: shinohara mm. J Natl Compr Canc Netw. 2022 Mar;20(3):285-308. doi: 10.6004/jnccn.2022.0015. J Natl Compr Canc Netw. 2022. PMID: 35276674
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Topalian SL, Bhatia S, Amin A, Kudchadkar RR, Sharfman WH, Lebbé C, Delord JP, Dunn LA, Shinohara MM, Kulikauskas R, Chung CH, Martens UM, Ferris RL, Stein JE, Engle EL, Devriese LA, Lao CD, Gu J, Li B, Chen T, Barrows A, Horvath A, Taube JM, Nghiem P. Topalian SL, et al. Among authors: shinohara mm. J Clin Oncol. 2020 Aug 1;38(22):2476-2487. doi: 10.1200/JCO.20.00201. Epub 2020 Apr 23. J Clin Oncol. 2020. PMID: 32324435 Free PMC article. Clinical Trial.
Sexual harassment from patient to provider.
Notaro E, Pascoe V, Shinohara MM, DeNiro K. Notaro E, et al. Among authors: shinohara mm. Int J Womens Dermatol. 2019 Sep 10;6(1):30-31. doi: 10.1016/j.ijwd.2019.09.001. eCollection 2020 Jan. Int J Womens Dermatol. 2019. PMID: 32042881 Free PMC article. No abstract available.
Inpatient Consultative Dermatology.
Biesbroeck LK, Shinohara MM. Biesbroeck LK, et al. Among authors: shinohara mm. Med Clin North Am. 2015 Nov;99(6):1349-64. doi: 10.1016/j.mcna.2015.06.004. Epub 2015 Sep 1. Med Clin North Am. 2015. PMID: 26476257 Review.
Skin Directed Therapy in Cutaneous T-Cell Lymphoma.
Tarabadkar ES, Shinohara MM. Tarabadkar ES, et al. Among authors: shinohara mm. Front Oncol. 2019 Apr 11;9:260. doi: 10.3389/fonc.2019.00260. eCollection 2019. Front Oncol. 2019. PMID: 31032224 Free PMC article. Review.
Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.
Glinos G, Wei G, Nosewicz J, Abdulla F, Chen PL, Chung C, Kaffenberger BH, Querfeld C, Shinohara MM, Sokol L, Zain J, Kumar A, Seminario-Vidal L. Glinos G, et al. Among authors: shinohara mm. JAMA Dermatol. 2023 Feb 1;159(2):192-197. doi: 10.1001/jamadermatol.2022.5740. JAMA Dermatol. 2023. PMID: 36598766 Free PMC article.
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker A, Burgess MA, Hanks BA, Olencki T, Kendra K, Church C, Akaike T, Ramchurren N, Shinohara MM, Salim B, Taube JM, Jensen E, Kalabis M, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL. Nghiem P, et al. Among authors: shinohara mm. J Immunother Cancer. 2021 Apr;9(4):e002478. doi: 10.1136/jitc-2021-002478. J Immunother Cancer. 2021. PMID: 33879601 Free PMC article. Clinical Trial.
91 results